BETOPTIC

This brand name is authorized in Austria, Australia, Brazil, Canada, Estonia, Spain, Finland, France, Hong Kong, Croatia, Japan, Lithuania, Malta, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug BETOPTIC contains one active pharmaceutical ingredient (API):

1 Betaxolol UNII 6X97D2XT0O - BETAXOLOL HYDROCHLORIDE

Betaxolol is a cardioselective Beta1 receptor blocker which, when applied topically to the eye, lowers intraocular pressure. It is thought to produce this effect by reducing the rate of production of aqueous humour. Read about Betaxolol

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
BETOPTIC Eye drops, suspension	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC
Betoptic Eye Drops Solution	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
S01ED02	Betaxolol	S Sensory organs → S01 Ophthalmologicals → S01E Antiglaucoma preparations and miotics → S01ED Beta blocking agents
Discover more medicines within S01ED02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 2825Q, 5544T
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 500900501172314, 526517090091403
Country: CA	Health Products and Food Branch	Identifier(s): 01908448
Country: EE	Ravimiamet	Identifier(s): 1034042
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 61015
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 061275, 098582, 423434
Country: FR	Base de données publique des médicaments	Identifier(s): 60100877
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 13842, 13844, 142101, 16194, 181547
Country: HK	Department of Health Drug Office	Identifier(s): 35281
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-709311743
Country: JP	医薬品医療機器総合機構	Identifier(s): 1319733Q1072
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1002498
Country: MT	Medicines Authority	Identifier(s): MA1249/00801
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 107M93
Country: NL	Z-Index G-Standaard	Identifier(s): 13741926, 14051907
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 37001, 46205
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 4635, 4636
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100010001, 100010018, 100255719, 100255731, 100262671, 100342217, 100399565, 100456318
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W69082001
Country: SG	Health Sciences Authority	Identifier(s): 04716P, 05837P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 21313011, 6643041, 6643042
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699839611475, 8699839611482
Country: US	FDA, National Drug Code	Identifier(s): 0065-0246
Country: ZA	Health Products Regulatory Authority	Identifier(s): 28/15.4/0716, S/15.4/371